Quantum-Si (QSI) vs Treace Medical Concepts (TMCI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Quantum-Si (QSI) has outperformed Treace Medical Concepts (TMCI) over the past year, losing 27.7% versus a loss of 35.2%. Over five years, TMCI leads with a -84.1% price change compared with -85.1% for QSI. Quantum-Si is the larger company by market cap ($267.0 million vs $252.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | QSI | TMCI |
|---|---|---|
| Share price | $1.22 | $3.88 |
| Market cap | $267.04M | $252.01M |
| 1-day change | -4.69% | -0.39% |
| YTD return | +16.36% | +58.78% |
| 1-year return | -27.68% | -35.17% |
| 5-year return | -85.12% | -84.07% |
| EPS (TTM) | $-0.45 | $-0.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.10 | $7.08 |
| 52-week low | $0.69 | $1.17 |
| Distance from 52-week high | -60.65% | -45.27% |
| Analyst consensus | buy | none |
| Avg. price target upside | +86.89% | +41.94% |
| Average volume | 4.10M | 330.27K |
| Shares outstanding | 198.95M | 65.03M |
| Employees | 145 | 450 |
| Sector | Industrials | Health Care |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Quantum-Si in Industrials and Treace Medical Concepts in Health Care.
About Quantum-Si
QSI stock →Quantum-Si incorporated, a life sciences company, develops proprietary, universal, and single-molecule detection platform applied to proteomics to enable next-gen protein sequencing (NGPS). The company offers Platinum and Platinum Pro NGPS instruments for single-molecule, amino acid level resolution, and automated data analysis; library preparation kits to prepare a customer's protein sample for sequencing; and sequencing kits, which contain the reagents and consumables used to perform NGPS.
Industrials · Industrial Machinery/Components · 145 employees
About Treace Medical Concepts
TMCI stock →Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions.
Health Care · Medical/Dental Instruments · 450 employees
QSI vs TMCI FAQ
Which is bigger, Quantum-Si or Treace Medical Concepts?
Quantum-Si (QSI) is larger, with a market capitalization of $267.04M compared with $252.01M for Treace Medical Concepts (TMCI).
Which stock has performed better over the past year, QSI or TMCI?
QSI returned -27.68% over the past 12 months, compared with -35.17% for TMCI (price return, excluding dividends). Past performance does not predict future results.
Are Quantum-Si and Treace Medical Concepts in the same industry?
No. Quantum-Si is in the Industrials sector, while Treace Medical Concepts is in Health Care.